Evaluating potential agents to prevent cancer
Contract Orientation and Kickoff Meeting
This study is looking at different potential treatments that might help prevent cancer, and it's designed to find safe and effective options that could benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11032070 on NIH RePORTER |
What this research studies
This research focuses on assessing the pharmacological and toxicological effects of various potential cancer preventive agents. By utilizing resources from contracts, the study aims to support the development of multiple candidate agents that could help in cancer prevention. Patients may benefit from this research as it seeks to identify effective strategies to reduce cancer risk through innovative treatments. The approach involves rigorous testing and evaluation to ensure safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for cancer or those interested in preventive measures against cancer.
Not a fit: Patients who are currently diagnosed with cancer or those who do not have a family history of cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventive treatments that significantly lower the risk of developing cancer.
How similar studies have performed: Previous research has shown promise in evaluating cancer preventive agents, indicating that this approach has potential for success.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Lyubimov, Alexander V — University of Illinois at Chicago
- Study coordinator: Lyubimov, Alexander V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.